Matarin Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.71M | Sell |
|
|||||
|
2020
Q3 | $3.15M | Sell |
|
|||||
|
2020
Q2 | $6.71M | Sell |
|
|||||
|
2020
Q1 | $5.73M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $6.93M | Sell |
|
|||||
|
2019
Q1 | $18.7M | Sell |
|
|||||
|
2018
Q4 | $22M | Sell |
|
|||||
|
2018
Q3 | $24.6M | Buy |
|
|||||
|
2018
Q2 | $17.2M | Sell |
|
|||||
|
2018
Q1 | $18.5M | Buy |
|
|||||
|
2017
Q4 | $15.1M | Buy |
|
|||||
|
2017
Q3 | $12.5M | Buy |
|
|||||
|
2017
Q2 | $8.91M | Buy |
|
|||||
|
2017
Q1 | $7.48M | Buy |
|
|||||
|
2016
Q4 | $7.48M | Buy |
|
|||||
|
2016
Q3 | $6.93M | Buy |
|
|||||
|
2016
Q2 | $5.9M | Buy |
|
|||||
|
2016
Q1 | $7.62M | Buy |
|
|||||
|
2015
Q4 | $7.95M | Buy |
|
|||||
|
2015
Q3 | $5M | Buy |
|
|||||
|
2015
Q2 | $3.36M | Buy |
|
|||||
|
2015
Q1 | $2.17M | Sell |
|
|||||
|
2014
Q4 | $2.25M | Sell |
|
|||||
|
2014
Q3 | $1.81M | Sell |
|
|||||
|
2014
Q2 | $1.93M | Buy |
|
|||||
|
2014
Q1 | $1.8M | Sell |
|
|||||
|
2013
Q4 | $1.76M | Buy |
|
|||||
|
2013
Q3 | $771K | Buy |
|
|||||
|
2013
Q2 | $503K | Buy |
|